A comparative study between metoprolol tartrate and metoprolol succinate

A comparative study between hemodynamic effect of metoprolol tartrate and metoprolol succinate in Acute Coronary Syndrome patients who admitted in Imam Ali hospital in Kermanshah city, 2015

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016010425839N1

Enrollment

Registered

2016-02-02

Start date

2015-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome. Acute Ischaemic Heart Disease

Interventions

Intervention 1: Metoprolol tartrate, tablet 25-50mg, BID or QID. Intervention 2: Metoprolol succinate 23.75 or 47.5 mg OD or BID.

Treatment - Drugs

Metoprolol tartrate, tablet 25-50mg, BID or QID.

Metoprolol succinate 23.75 or 47.5 mg OD or BID

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age older than18 years old with Acute Coronary Syndrome diagnosis. Exclusion criteria: age less than 18 years old; severe pulmonary disease and severe asthma; use of other beta blockers; use of calcium channel blocker, digoxin; II and III degree heart block; peripheral vascular disease and Diabetes Melitus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: At admission until 72 hours. Method of measurement: mm Hg by mercuric manometer.;Heart rate. Timepoint: At admission until 72 hours. Method of measurement: By physician.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Maziar Rezvani Gil Kolaee

Kermanshah University of Medical Sciences, Imam Ali Hospital

maziar718@yahoo.com+98 83 3837 0252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026